Abstract:Objective: To investigate the preliminary applicability of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) score in the condition of 3.0T multi-parametric magnetic resonance imaging (Mp-MRI) combined with clinical classic indicators for the diagnosis of prostate cancer (PCa). Methods: The clinical and MRI materials of 247 patients of suspicious prostate disease treated in Second Affiliated Hospital of Soochow University from June 2015 to November 2016 were analyzed retrospectively, including 110 cases with PCa and 137 cases without cancer.All cases underwent the high-resolution axial T(2)-weighted imaging (T(2)WI), diffusion weighted imaging (DWI) and dynamic contrast enhancement-magnetic resonance imaging (DCE-MRI) and were confirmed pathologically by puncture biopsies.The Mp-MRI materials of all cases were scored according to PI-RADS v2.The prostate volume and prostate specific antigen (PSA) density (PSAD) value were calculated according to the formulas.The univariate and multivariate analysis were performed for the observed indicators (age, prostate volume, PSA, PSAD and PI-RADS v2 score) to determine the independent predictors for PCa.Then, a Logistic regression model (combined prediction model) was established by the independent predictors for combined diagnosis of PCa.The receiver operating characteristic curve (ROC) curve analysis was performed to get the sensitivity and specificity of each independent predictor and the model to diagnose PCa.The differences of AUC values of each independent predictor and the model were compared with each other to evaluate the diagnostic performance for PCa. Results: The differences in the age, prostate volume, PSA, PSAD and the PI-RADS v2 score between patients with PCa and non-cancer group were all statistically significant (t=2.870, Z=-4.230, -7.787, -9.477, -10.826, all P<0.05). The PSAD and PI-RADS v2 score were independent predictors for PCa (OR=3.331, 10.546, both P<0.05). The Logistic regression combined prediction model by PI-RADS v2 score and PSAD to forecast PCa was Logit(P)=-5.097+ 2.309×PSAD+ 1.214×PI-RADS v2 score.The area under the curve (AUC) of ROC in the combined model (0.911) was higher than that in the PI-RADS v2 score (0.886) and PSAD (0.851) and the differences were all statistically significant (Z=2.416, 2.716, both P<0.05); but the difference in the AUC value between PI-RADS v2 score and PSAD was not statistically significant (Z=1.191, P=0.234). The diagnostic sensitivity of PSAD, PI-RADS v2 score and the model were: 0.891, 0.782 and 0.855, respectively; the specificity were 0.449, 0.912 and 0.847, respectively on their positive thresholds (0.15 μg·L(-1)·ml(-1,) 4 and -0.82). Conclusion: PI-RADS v2 score combined with PSAD in diagnosing PCa is superior to the single application of them and it can lead to high diagnostic sensitivity and specificity for PCa.

Characterristics of Three-Dimensional Magnetic Resonance Spectroscopy of Prostatic Intraepithelial Neoplasia

Study of 3D-magnetic resonance spectroscopy imaging in prostate cancer and benign prostate hyperplasia

Study of 3-Dimensional Magnetic Resonance Spectroscopy Quantitative Analysis in the Differential diagnosis of Prostate Lesions

Three-dimensional Proton Magnetic Resonance Spectroscopy and Diffusion-Weighted Imaging in the Differentiation of Incidental Prostate Carcinoma from Benign Prostate Hyperplasia.

Value of 3D 1H-MRS with Body Coil at 3T in the Differential Diagnosis of the Prostate Cancer

Differential diagnosis of diffuse lesion in peripheral zone of prostate by using multi-parametric MRI

Role of MR Spectroscopy by Using Endo-rectal Coil in the Differential Diagnosis of Prostatic Carcinoma

[Application of Dynamic Contrast Enhanced Status in Multiparametric Magnetic Resonance Imaging for Prostatic Cancer with PI-RADS 4 Lesion].

Applied Research on Prostate Cancer by MRI and 3DMRSI

The value of MRS integratel MRI in the differential diagnosis of prostate adenocarcinoma and benign prostate hyperplasia

Quantitative Analysis of Incidentally Detected Prostate Carcinoma and Prostate Cancer in the Central Gland of Prostate with MRS

The value of 3.0T DCE-MRI in the diagnosis of prostate cancer

Clinical Value of Magnetic Resonance Spectroscopy by ROC Curve in Diagnosis of Prostate Cancer

Study of the Correlation between MRS and Diffusion-Weighted MR Imaging in the Prostatic Cancer

[Preliminary Applicability Evaluation of Prostate Imaging Reporting and Data System Version 2 Diagnostic Score in 3.0T Multi-Parameters Magnetic Resonance Imaging Combined with Prostate Specific Antigen Density for Prostate Cancer].

The value of multiparametric MRI examination using 1.5T and 3.0T with PI-RADS (version 2) in the qualitative diagnosis of clinically significant prostate cancer

The Feature and Clinical Significance of Serum PSA and PSAD in Patients with Prostatic Intraepithelial Neopiasia

Magnetic Resonance Spectroscopy Imaging In Diagnosis Of Suspicious Prostate Cancer A Meta-Analysis

MRS in the Differential Diagnosis of Low T2 Signal Diseases in Peripheral Zone of Prostate: Prostatitis and Prostatic Carcinoma

Diagnostic Performance of Multiparametric MRI Parameters for Gleason Score and Cellularity Metrics of Prostate Cancer in Different Zones: a Quantitative Comparison

Application value of magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer